Loading…

A modified technique for measurement of nasal transepithelial potential difference in infants

Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 wi...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pediatrics 2001-09, Vol.139 (3), p.353-358
Main Authors: Southern, Kevin W., Noone, Peadar G., Bosworth, Darin G., LeGrys, Vicky A., Knowles, Michael R., Barker, Pierre M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3
cites cdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3
container_end_page 358
container_issue 3
container_start_page 353
container_title The Journal of pediatrics
container_volume 139
creator Southern, Kevin W.
Noone, Peadar G.
Bosworth, Darin G.
LeGrys, Vicky A.
Knowles, Michael R.
Barker, Pierre M.
description Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)
doi_str_mv 10.1067/mpd.2001.116278
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71173505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002234760195173X</els_id><sourcerecordid>71173505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</originalsourceid><addsrcrecordid>eNp1kMtLAzEQh4Motj7O3mRP3rbOJN2kexTxBQUvepSQzU5oZF8mqeB_b0oLnoSBzDBffiQfY1cICwSpbvupXXAAXCBKrlZHbI5Qq1KuhDhmcwDOS7FUcsbOYvwEgHoJcMpmiJXkEsWcfdwV_dh656ktEtnN4L-2VLgxFD2ZuA3U05CK0RWDiaYrUjBDpMmnDXU-z9OY8n7X5QxHgQZLhR9yOTOkeMFOnOkiXR7Oc_b--PB2_1yuX59e7u_WpRVLkUpZ1_XKusYKFHJplalBAXe8IcdXSNiiaMDxtiKhbGVVLRoliWyDjQVXOXHObva5Uxjz-2PSvY-Wus4MNG6jVohKVFBl8HYP2jDGGMjpKfjehB-NoHdGdTaqd0b13mi-cX2I3jY9tX_8QWEG6j1A-YPfnoKO1u88tD6QTbod_b_hv4y8hpE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71173505</pqid></control><display><type>article</type><title>A modified technique for measurement of nasal transepithelial potential difference in infants</title><source>ScienceDirect Freedom Collection</source><creator>Southern, Kevin W. ; Noone, Peadar G. ; Bosworth, Darin G. ; LeGrys, Vicky A. ; Knowles, Michael R. ; Barker, Pierre M.</creator><creatorcontrib>Southern, Kevin W. ; Noone, Peadar G. ; Bosworth, Darin G. ; LeGrys, Vicky A. ; Knowles, Michael R. ; Barker, Pierre M.</creatorcontrib><description>Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1067/mpd.2001.116278</identifier><identifier>PMID: 11562613</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adult ; Amiloride ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - genetics ; Differential Threshold ; Diuretics ; Genotype ; Humans ; Infant ; Infant, Newborn ; Nasal Mucosa</subject><ispartof>The Journal of pediatrics, 2001-09, Vol.139 (3), p.353-358</ispartof><rights>2001 Mosby, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</citedby><cites>FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11562613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Southern, Kevin W.</creatorcontrib><creatorcontrib>Noone, Peadar G.</creatorcontrib><creatorcontrib>Bosworth, Darin G.</creatorcontrib><creatorcontrib>LeGrys, Vicky A.</creatorcontrib><creatorcontrib>Knowles, Michael R.</creatorcontrib><creatorcontrib>Barker, Pierre M.</creatorcontrib><title>A modified technique for measurement of nasal transepithelial potential difference in infants</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)</description><subject>Adult</subject><subject>Amiloride</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - genetics</subject><subject>Differential Threshold</subject><subject>Diuretics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Nasal Mucosa</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kMtLAzEQh4Motj7O3mRP3rbOJN2kexTxBQUvepSQzU5oZF8mqeB_b0oLnoSBzDBffiQfY1cICwSpbvupXXAAXCBKrlZHbI5Qq1KuhDhmcwDOS7FUcsbOYvwEgHoJcMpmiJXkEsWcfdwV_dh656ktEtnN4L-2VLgxFD2ZuA3U05CK0RWDiaYrUjBDpMmnDXU-z9OY8n7X5QxHgQZLhR9yOTOkeMFOnOkiXR7Oc_b--PB2_1yuX59e7u_WpRVLkUpZ1_XKusYKFHJplalBAXe8IcdXSNiiaMDxtiKhbGVVLRoliWyDjQVXOXHObva5Uxjz-2PSvY-Wus4MNG6jVohKVFBl8HYP2jDGGMjpKfjehB-NoHdGdTaqd0b13mi-cX2I3jY9tX_8QWEG6j1A-YPfnoKO1u88tD6QTbod_b_hv4y8hpE</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Southern, Kevin W.</creator><creator>Noone, Peadar G.</creator><creator>Bosworth, Darin G.</creator><creator>LeGrys, Vicky A.</creator><creator>Knowles, Michael R.</creator><creator>Barker, Pierre M.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>A modified technique for measurement of nasal transepithelial potential difference in infants</title><author>Southern, Kevin W. ; Noone, Peadar G. ; Bosworth, Darin G. ; LeGrys, Vicky A. ; Knowles, Michael R. ; Barker, Pierre M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Amiloride</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - genetics</topic><topic>Differential Threshold</topic><topic>Diuretics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Nasal Mucosa</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Southern, Kevin W.</creatorcontrib><creatorcontrib>Noone, Peadar G.</creatorcontrib><creatorcontrib>Bosworth, Darin G.</creatorcontrib><creatorcontrib>LeGrys, Vicky A.</creatorcontrib><creatorcontrib>Knowles, Michael R.</creatorcontrib><creatorcontrib>Barker, Pierre M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Southern, Kevin W.</au><au>Noone, Peadar G.</au><au>Bosworth, Darin G.</au><au>LeGrys, Vicky A.</au><au>Knowles, Michael R.</au><au>Barker, Pierre M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A modified technique for measurement of nasal transepithelial potential difference in infants</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>139</volume><issue>3</issue><spage>353</spage><epage>358</epage><pages>353-358</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Objective: To establish a method for measuring nasal transepithelial potential difference (PD) in infants. Study design: A modified infant method (smaller catheter size, reduced flow rates, and shorter protocol time) was compared with an established adult nasal PD method in 10 adult volunteers (4 with cystic fibrosis [CF]). Nasal PD was measured in 13 infants with a possible diagnosis of CF. Results: Recordings were similar for the established and the modified methods in adult volunteers. An amiloride concentration of 10–4 mol/L was necessary for full inhibition of amiloride-sensitive sodium ion (Na+) transport. Of the 13 infants, 2 had PD values suggestive of CF (mean baseline PD, –50.1 mV and –31.4 mV; maximum baseline PD, –61 mV and –49 mV; change in PD after perfusion with zero chloride solution with isoprenaline and amiloride [ΔzeroCl–/Iso], –1 mV and +3.5 mV), and 11 had normal values (mean ± SEM baseline PD, –13.2 ± 1.0 mV; maximum baseline PD, –21.4 ± 2.0; ΔzeroCl–/Iso, –15.3 ± 1.9 mV). These results correlated with subsequent sweat test data, mutation analysis, and clinical outcome. Conclusion: Nasal PD measured with this modified method is comparable to that measured with an established adult method. The measurements were well tolerated in 13 infants and discriminated bioelectric profiles characteristic of normal and CF respiratory epithelium. This study supports the use of this modified nasal PD technique as a diagnostic test for CF in newborn infants. (J Pediatr 2001;139:353-8)</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>11562613</pmid><doi>10.1067/mpd.2001.116278</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 2001-09, Vol.139 (3), p.353-358
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_71173505
source ScienceDirect Freedom Collection
subjects Adult
Amiloride
Cystic Fibrosis - diagnosis
Cystic Fibrosis - genetics
Differential Threshold
Diuretics
Genotype
Humans
Infant
Infant, Newborn
Nasal Mucosa
title A modified technique for measurement of nasal transepithelial potential difference in infants
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T22%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20modified%20technique%20for%20measurement%20of%20nasal%20transepithelial%20potential%20difference%20in%20infants&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Southern,%20Kevin%20W.&rft.date=2001-09-01&rft.volume=139&rft.issue=3&rft.spage=353&rft.epage=358&rft.pages=353-358&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1067/mpd.2001.116278&rft_dat=%3Cproquest_cross%3E71173505%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c343t-69998cfbc31364c7a90702f2bef281e1d13b0f2d5e37c5c793b76eecb1bc0f5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71173505&rft_id=info:pmid/11562613&rfr_iscdi=true